BIRMINGHAM, Ala. – Pathways to new treatments for heart failure take time — as long as four decades for two now accepted therapies. So, new attempts ...
Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein =2 mg/L; p=0.003) and ischemic HFrEF etiology ...